Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd. — Natural Product Compound Library | Innovative Drug Discovery | Spectral Intelligence | Micro-ED Analysis

Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd. Healthy Roots Biotechnology (Shenzhen) Co., Limited Joint Development

中文 EN

Home

Products

NP Database

Services

Tech Insights

About

Contact

中文 EN

Plant Sources

Structural Classes

Microbial Sources

Flagship Varieties

Synthetic Compounds

CAS No.	NAME	Molecular Formula	Molecular Weight	Purity	Price	2D Structure
914361-45-8	Fosravuconazole L-lysine ethanolate CCO.CC(C1=NC(=CS1)C2=CC=C(C=C2)C#N)C(CN3C=NC=N3)(C4=C(C=C(C=C4)F)F)OCOP(=O)(O)O.C(CCN)CC(C(=O)O)N	C₃₁H₄₀F₂N₇O₈PS	739.7	98%	Click to inquire
2314467-60-0	TRPV4 agonist-1 CN1CCN(CC1)C2=NC3=C(C=CC=C3F)C(=O)N2C4=CC=C(C=C4)OC5=CC=C(C=C5)F.Cl	C₂₅H₂₃ClF₂N₄O₂	484.9	98%	Click to inquire
2319790-02-6	SSD114 hydrochloride COC1=NC(=NC(=C1)C2=CC=C(C=C2)C(F)(F)F)NC3CCCCC3.Cl	C₁₈H₂₁ClF₃N₃O	387.8	98%	Click to inquire
2288709-96-4	N-Methyl-4-(6-phenylimidazo[1,2-a]pyrazin-3-yl)benzamide CNC(=O)C1=CC=C(C=C1)C2=CN=C3N2C=C(N=C3)C4=CC=CC=C4	C₂₀H₁₆N₄O	328.4	98%	Click to inquire
2095432-58-7	SAG HCl CNC1CCC(CC1)N(CC2=CC(=CC=C2)C3=CC=NC=C3)C(=O)C4=C(C5=CC=CC=C5S4)Cl.Cl	C₂₈H₂₉Cl₂N₃OS	526.5	98%	Click to inquire
248282-01-1	Paquinimod CCC1=C2C(=CC=C1)N(C(=O)C(=C2O)C(=O)N(CC)C3=CC=CC=C3)C	C₂₁H₂₂N₂O₃	350.4	98%	Click to inquire
724453-98-9	Diflapolin CC1=C(C=CC(=C1)OCC2=NC3=CC=CC=C3S2)NC(=O)NC4=CC(=C(C=C4)Cl)Cl	C₂₂H₁₇Cl₂N₃O₂S	458.4	98%	Click to inquire
384859-58-9	2-[[3-Ethoxycarbonyl-6-(trifluoromethoxy)quinolin-4-yl]amino]benzoic acid CCOC(=O)C1=CN=C2C=CC(=CC2=C1NC3=CC=CC=C3C(=O)O)OC(F)(F)F	C₂₀H₁₅F₃N₂O₅	420.3	98%	Click to inquire
869489-04-3	(S)-4,4-Difluoropyrrolidine-2-carbonitrile hydrochloride C1C(NCC1(F)F)C#N.Cl	C₅H₇ClF₂N₂	168.57	98%	Click to inquire
2243736-35-6	2-((2,6-Dichloro-4-(3,5-dimethylisoxazol-4-yl)phenyl)amino)benzoic acid CC1=C(C(=NO1)C)C2=CC(=C(C(=C2)Cl)NC3=CC=CC=C3C(=O)O)Cl	C₁₈H₁₄Cl₂N₂O₃	377.2	98%	Click to inquire

Fosravuconazole L-lysine ethanolate

Fosravuconazole L-lysine ethanolate

C₃₁H₄₀F₂N₇O₈PS 739.7

TRPV4 agonist-1

C₂₅H₂₃ClF₂N₄O₂ 484.9

SSD114 hydrochloride

SSD114 hydrochloride

C₁₈H₂₁ClF₃N₃O 387.8

N-Methyl-4-(6-phenylimidazo[1,2-a]pyrazin-3-yl)benzamide

C₂₀H₁₆N₄O 328.4

SAG hydrochloride

C₂₈H₂₉Cl₂N₃OS 526.5

C₂₁H₂₂N₂O₃ 350.4

C₂₂H₁₇Cl₂N₃O₂S 458.4

2-[[3-Ethoxycarbonyl-6-(trifluoromethoxy)quinolin-4-yl]amino]benzoic acid

C₂₀H₁₅F₃N₂O₅ 420.3

(S)-4,4-Difluoropyrrolidine-2-carbonitrile hydrochloride

(S)-4,4-difluoropyrrolidine-2-carbonitrile hydrochloride

C₅H₇ClF₂N₂ 168.57

2-((2,6-Dichloro-4-(3,5-dimethylisoxazol-4-yl)phenyl)amino)benzoic acid

C₁₈H₁₄Cl₂N₂O₃ 377.2

< Previous 1 2 3 4 5 6 7 8 9 10 ... (Current page 15676) 16106 Next >

All products and services are for scientific research only. They may not be used for human administration, nor are they supplied to individual consumers.

Address: Room B410, Virtual University Park Key Laboratory Building, No. 1 Yuexing 2nd Road, High-Tech Zone Community, Yuehai Subdistrict, Nanshan District, Shenzhen

Phone: 400-856-5689

Email: kehuaai@kehuaai.com

Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd.

ICP Record No.: 粤ICP备2024241782号